Email UpdatesThis public meeting explored real-world experiences and scientific evidence on emerging data trends for human xylazine exposure and examined concrete strategies for drug development and clinical research.
Source
Regan-Udall Foundation for the FDA
Year
Format
Terms of Use
Audience
Resource Type
Special Collection